We’re proud to share that Cardea Health has secured $350,000 in non-dilutive government financing to accelerate our work at the intersection of AI and healthcare.

This support from the Government of Canada, delivered through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), is a strong vote of confidence in our vision to build AI-first clinical trial and RWE (Real World Evidence) infrastructure for North America.

This funding enables us to deepen our investment in applied AI that transforms how patients are identified and matched into clinical trials for RWE initiatives across outpatient care settings. Our focus is on creating scalable, explainable, and compliant AI solutions that meaningfully reduce trial timelines, improve data quality, and expand patient access to research.

With this support, we are well-positioned to become leaders in Clinical Trials and AI across North America, helping sponsors, sites, and physicians unlock the full potential of real-world clinical data.

We’re grateful to the Government of Canada for backing Canadian AI innovation and helping companies like ours build globally competitive health-tech platforms.

 Government of Canada fuels AI growth for businesses in southern Ontario – Canada.ca